ARK Genomic Revolution ETF (BATS:ARKG) Stock Price Crosses Above 50 Day Moving Average – Here’s Why

Shares of ARK Genomic Revolution ETF (BATS:ARKG) crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $49.46 and traded as high as $51.99. ARK Genomic Revolution ETF shares last traded at $51.65, with a volume of 6,004,095 shares trading hands.

ARK Genomic Revolution ETF Stock Up 6.0%

The company’s 50 day moving average price is $49.46 and its two-hundred day moving average price is $37.03.

Hedge Funds Weigh In On ARK Genomic Revolution ETF

Hedge funds have recently added to or reduced their stakes in the company. Oppenheimer & Co. Inc. purchased a new stake in ARK Genomic Revolution ETF in the 3rd quarter worth about $1,627,000. Park Avenue Securities LLC purchased a new position in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $336,000. Flagship Harbor Advisors LLC purchased a new position in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $229,000. Kingswood Wealth Advisors LLC purchased a new position in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $219,000. Finally, Sigma Planning Corp bought a new position in shares of ARK Genomic Revolution ETF during the third quarter valued at approximately $494,000.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.